Tectonic Therapeutic, Inc. — Director's Dealing 2020

Feb 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2020-02-13

Reporting Person: ATLAS VENTURE ASSOCIATES X, L.P. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-13	Common Stock	J	1046426	$0.00	Disposed	3710052	Direct

Footnotes

F1: Represents a pro rata distribution, and not a purchase or sale of securities, by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") to its general partner and limited partners without additional consideration, pursuant to Atlas Venture Fund X's Rule 10b5-1 plan dated July 23, 2019.